Servicii de arhitectură şi servicii conexe
Information about customer
Title
IMSP Institutul Oncologic
IDNO
1003600151023
Address
MOLDOVA,
locality,
str. Testemitanu, 30,
MD 2025
The contact person
Adam Ana,
achizitii@onco.md
Purchase data
ID
ocds-b3wdp1-MD-1666620249315
Title
Servicii de arhitectură şi servicii conexe
Note
CPV Code
71200000-0 - Servicii de arhitectură şi servicii conexe
Rationale
List of funding sources
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1666620250231
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1666620250107
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1667820290836
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1668169850156
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1667820290970
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1668169850028
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670342272662
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670342272016
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670342272485
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670342272145
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670342272308
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670342272831
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670487077503
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670487077097
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670487076699
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670487076519
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670487076907
IBAN
None
Funding source cost
420000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1666620249315-FS-1670487077307
IBAN
None
Status Planning
Start the procedure:
1 Jan 2022
1 Jan 2023
Date of publication: 24 Oct 2022 17:04
Date of last modifications: 20 Dec 2022 18:36